Primary efficacy and safety of adalimumab in nail psoriasis from the first 26weeks of a phase-3, randomized, placebo-controlled trial with subanalysis in patients with and without psoriatic arthritis

被引：0
|
作者：
Elewski, Boni E. [1 ]
Rich, Phoebe A. [2 ]
Behrens, Frank [3 ]
Guillet, Gerard [4 ]
Geng, Ziqian [5 ]
Servin, Ofelia Reyes [5 ]
机构：
[1] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA
[2] Oregon Hlth & Sci Univ Hosp, Portland, OR USA
[3] Goethe Univ, Med Ctr, Frankfurt, Germany
[4] CHU Poitiers, Serv Dermatol, Hop Mil, Poitiers, France
[5] AbbVie Inc, N Chicago, IL USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2017年 / 76卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
5081
引用
收藏
页码：AB204 / AB204
页数：1
相关论文
共 50 条
  • [21] Secukinumab efficacy and safety in Japanese patients with moderate-to-severe plaque psoriasis: Subanalysis from ERASURE, a randomized, placebo-controlled, phase 3 study
    Ohtsuki, Mamitaro
    Morita, Akimichi
    Abe, Masatoshi
    Takahashi, Hidetoshi
    Seko, Noriko
    Karpov, Alexander
    Shima, Tomohiro
    Papavassilis, Charis
    Nakagawa, Hidemi
    [J]. JOURNAL OF DERMATOLOGY, 2014, 41 (12): : 1039 - 1046
  • [22] Efficacy and Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, or Adalimumab in Patients with Active Psoriatic Arthritis and an Inadequate Response to Conventional Synthetic Dmards: A Randomized, Placebo-Controlled, Phase 3 Trial
    Mease, Philip J.
    Hall, Stephen
    FitzGerald, Oliver
    van der Heijde, Desiree
    Merola, Joseph F.
    Avila-Zapata, Francisco
    Cieslak, Dorata
    Graham, Daniela
    Wang, Cunshan
    Menon, Sujatha
    Hendrikx, Thijs
    Kanik, Keith
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [23] Efficacy of Adalimumab Compared With Methotrexate or Placebo Stratified by Baseline BMI in a Randomized Placebo-Controlled Trial in Patients With Psoriasis
    Prussick, Ronald
    Unnebrink, Kristina
    Valdecantos, Wendell C.
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2015, 14 (08) : 864 - 868
  • [24] Efficacy and safety of adalimumab in patients with moderate to severe hidradenitis suppurativa: Results from PIONEER II, a phase 3, randomized, placebo-controlled trial
    Jemec, Gregor
    Gottlieb, Alice
    Forman, Seth
    Giamarellos-Bourboulis, Evangelos
    Reguiai, Ziad
    Gu, Yihua
    Okun, Martin
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB45 - AB45
  • [25] Efficacy and safety of adalimumab in Chinese patients with moderate to severe plaque psoriasis: Results from a phase 3, randomized, placebo-controlled, double-blind Study
    Zhang, Jianzhong
    Gu, Jun
    Zheng, Jie
    Zheng, Min
    Wang, Gang
    Gu, Yihua
    Okun, Martin
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB232 - AB232
  • [26] Golimumab in psoriatic arthritis: One-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial
    Kavanaugh, Arthur
    van der Heijde, Desiree
    McInnes, Iain B.
    Mease, Philip
    Krueger, Gerald G.
    Gladman, Dafna D.
    Gomez-Reino, Juan
    Papp, Kim
    Baratelle, Anna
    Xu, Weichun
    Mudivarthy, Surekha
    Mack, Michael
    Rahman, Mahboob U.
    Xu, Zhenhua
    Zrubek, Julie
    Beutler, Anna
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (08): : 2504 - 2517
  • [27] EFFICACY AND SAFETY OF ADALIMUMAB IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS - AN INVESTIGATOR-INITIATED RANDOMIZED PLACEBO-CONTROLLED TRIAL
    Krabbe, S.
    Ostergaard, M.
    Sorensen, I. J.
    Jensen, B.
    Madsen, O. R.
    Eng, G. P.
    Asmussen, K. H.
    Moller, J.
    Balding, L.
    Pedersen, S. J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1131 - 1132
  • [28] Efficacy and Safety Results of Guselkumab in Patients with Active Psoriatic Arthritis over 56 Weeks from a Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study
    Deodhar, Atul A.
    Gottlieb, Alice B.
    Boehncke, Wolf-Henning
    Dong, Bin
    Wang, Yuhua
    Zhuang, Yanli
    Barchuk, William
    Xu, Xie L.
    Hsia, Elizabeth
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [29] EFFICACY AND SAFETY OF SELADELPAR IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS IN THE RESPONSE TRIAL: A PHASE 3 INTERNATIONAL, RANDOMIZED, PLACEBO-CONTROLLED STUDY
    Hirschfield, Gideon M.
    Bowlus, Christopher L.
    Mayo, Marlyn J.
    Kremer, Andreas E.
    Vierling, John M.
    Kowdley, Kris V.
    Levy, Cynthia
    Carroll, Susheela
    Yang, Ke
    Choi, Yun-Jung
    Crittenden, Daria B.
    McWherter, Charles A.
    [J]. HEPATOLOGY, 2024, 79 (02) : E34 - E35
  • [30] Efficacy and safety of adalimumab in Chinese patients with moderate-to-severe plaque psoriasis: results from a phase 3, randomized, placebo-controlled, double-blind study
    Cai, L.
    Gu, J.
    Zheng, J.
    Zheng, M.
    Wang, G.
    Xi, L. -Y.
    Hao, F.
    Liu, X. -M.
    Sun, Q. -N.
    Wang, Y.
    Lai, W.
    Fang, H.
    Tu, Y. -T.
    Sun, Q.
    Chen, J.
    Gao, X. -H.
    Gu, Y.
    Teixeira, H. D.
    Zhang, J. -Z.
    Okun, M. M.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (01) : 89 - 95
12345